Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer

William D. Figg*, Oliver Sartor, Michael R. Cooper, Alain Thibault, Raymond C. Bergan, Nancy Dawson, Eddie Reed, Charles E. Myers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

79 Scopus citations
Original languageEnglish
Pages (from-to)412-414
Number of pages3
JournalThe American Journal of Medicine
Volume98
Issue number4
DOIs
StatePublished - Apr 1995
Externally publishedYes

Fingerprint

Dive into the research topics of 'Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer'. Together they form a unique fingerprint.

Cite this